http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102427097-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S514-863 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate | 2015-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102427097-B1 |
| titleOfInvention | Method for treating psoriasis patient which received anti-tnf-alpha antibody therapy |
| abstract | The present invention relates to a therapeutic agent for pustular psoriasis or erythroderma psoriasis administered to a patient with psoriasis administered with an anti-TNF-alpha antibody, comprising an IL-17RA antagonist as an active ingredient, and an anti-inflammatory agent comprising an IL-17RA antagonist as an active ingredient To a therapeutic agent for psoriasis administered to patients with psoriasis that cannot be treated with -TNF-alpha antibody. In addition, the present invention provides a method for treating pustular psoriasis or erythroderma psoriasis, comprising administering an IL-17RA antagonist to a psoriasis patient to whom an anti-TNF-alpha antibody has been administered; and to a method of treating psoriasis comprising administering an IL-17RA antagonist to a patient with psoriasis that cannot be treated with an anti-TNF-alpha antibody. |
| priorityDate | 2014-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 219.